Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells

L. Salazar, O. Aravena, P. Abello, A. Escobar, J. Contreras-Levicoy, N. Rojas-Colonelli, D. Catalán, A. Aguirre, R. Zúñiga, B. Pesce, C. González, R. Cepeda, M. Cuchacovich, M. C. Molina, F. Salazar-Onfray, M. Delgado, R. E. Toes, J. C. Aguillón

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)


Background: The use of regulatory or immature dendritic cells (DCs) as tools for modulating experimental rheumatoid arthritis is very recent. Tumour necrosis factor (TNF)-stimulated DCs have been shown to restore tolerance in experimental autoimmune encephalomyelitis and collagen-induced arthritis (CIA). Objective: We investigated the capacity of short-term lipopolysacchahde (LPS)-stimulated DCs pulsed with type II collagen (CII) to induce tolerance against established CIA. Methods: Bone marrow-derived DCs were generated in the presence of granulocyte monocyte colony-stimulating factor (GM-CSF). After CIA induction, mice were injected at day 35 with a single dose of 4- or 24-h LPS-stimulated DCs that had been loaded with CII (4hLPS/CII/DCs or 24hLPS/CII/DCs). Arthritis progression was monitored by clinical and histological evaluations. Results: Flow cytometry of 4hLPS/CII/DCs showed intermediate CD40 and CD86 expression, lower than that of 24hLPS/CII/DCs (fully mature) and higher than that of CII/DCs (immature). A functional assay showed that 4hLPS/CII/DCs display increased endocytosis ability with respect to 24hLPS/CII/DCs, indicating a semimature state. The single inoculation of 4hLPS/CII/DCs in mice with established CIA reduced disease severity significantly over time. Histological evaluation of mice treated with 4hLPS/CII/DCs revealed diminished inflammatory synovitis, cartilage damage and fibrosis. Co-cultures of DCs with splenocytes from CIA mice showed that collagen-specific interferon (IFN)γ production was dramatically inhibited by 4hLPS/CII/DCs. 4hLPS/CII/DCs were high IL10 producers, which could explain the inhibition of arthritis progression in mice receiving this treatment because neither antibodies nor regulatory CD4+CD25+Foxp3+ T lymphocytes were demonstrated to be involved. Conclusion: Short-term LPS-modulated DCs inoculation interferes with CIA progression when loaded with CII.

Original languageEnglish
Pages (from-to)1235-1241
Number of pages7
JournalAnnals of the Rheumatic Diseases
Issue number9
Publication statusPublished - Sept 2008

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • General Biochemistry,Genetics and Molecular Biology

Cite this